Eton Pharmaceutcials, Inc. does not report diluted earnings per share for fiscal year 2025, so the figure is not reported on this page. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Eton Pharmaceutcials, Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Eton Pharmaceutcials, Inc. does not report diluted earnings per share for fiscal year 2025, so the figure is not reported on this page.
Eton Pharmaceutcials, Inc. (ETON) reported $1.06 in diluted earnings per share in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Eton Pharmaceutcials, Inc. (ETON) reported on that line in every period on record.